Key Record Dates
ClinicalTrials.gov Identifier: | NCT05668091 |
---|---|
Brief Title: | A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults With Long COVID. |
First Submitted : | December 24, 2022 |
First Submitted that Met QC Criteria : | December 24, 2022 |
First Posted : | December 29, 2022 |
Last Update Submitted that Met QC Criteria : | March 4, 2024 |
Last Update Posted : | March 5, 2024 |